Pathogenesis from Inflammation to Cancer in NASH-Derived HCC.
Yu S, Wang J, Zheng H, Wang R, Johnson N, Li T, Li P, Lin J, Li Y, Yan J, Zhang Y, Zhu Z, Ding X.
Yu S, et al.
J Hepatocell Carcinoma. 2022 Aug 26;9:855-867. doi: 10.2147/JHC.S377768. eCollection 2022.
J Hepatocell Carcinoma. 2022.
PMID: 36051860
Free PMC article.
Review.